Related Experiment Video
Updated: Jun 26, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Genomic characteristics of soft tissue sarcomas
Fredrik Mertens1, Ioannis Panagopoulos, Nils Mandahl
1Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. Fredrik.mertens@med.lu.se
Virchows Archiv : an International Journal of Pathology
|February 4, 2009
Summary
Soft tissue sarcomas are genetically diverse. Genomic analysis reveals distinct groups, aiding in understanding tumor development and patient diagnosis.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Soft tissue sarcomas exhibit significant clinical, morphological, and genetic heterogeneity.
- Current understanding of sarcoma genetics is primarily at the genomic level, utilizing techniques like chromosome banding and comparative genomic hybridization.
Purpose of the Study:
- To review the genomic characterization of soft tissue sarcomas.
- To highlight the diagnostic utility of genomic findings for clinicians.
Main Methods:
- Review of existing genomic studies on soft tissue sarcomas.
- Analysis of data from chromosome banding and comparative genomic hybridization.
Main Results:
- Soft tissue sarcomas can be broadly classified into two groups based on genomic alterations.
- Approximately 20% of sarcomas are characterized by specific balanced translocations.
- The remaining sarcomas typically display massive chromosomal rearrangements, often recurrent but non-specific.
Conclusions:
- Genomic characterization provides crucial insights into genes essential for soft tissue sarcoma development.
- Genomic findings serve as a valuable diagnostic tool for managing patients with soft tissue sarcomas.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...